Ocuphire Pharma EBIT 2010-2024 | IRD

Ocuphire Pharma ebit from 2010 to 2024. Ebit can be defined as earnings before interest and taxes.

Ocuphire Pharma Annual EBIT (Millions of US $)
2023	$-11
2022	$18
2021	$-23
2020	$-20
2019	$-4
2018	$-21
2017	$-17
2016	$-16
2015	$-18
2014	$-13
2013	$-8
2012	$-7
2011	$-16
2010	$-10
2009	$-6

Ocuphire Pharma Quarterly EBIT (Millions of US $)
2024-06-30	$-8
2024-03-31	$-8
2023-12-31	$-5
2023-09-30	$6
2023-06-30	$-5
2023-03-31	$-6
2022-12-31	$34
2022-09-30	$-5
2022-06-30	$-5
2022-03-31	$-7
2021-12-31	$-6
2021-09-30	$-4
2021-06-30	$-7
2021-03-31	$-5
2020-12-31	$-14
2020-09-30	$-2
2020-06-30	$-1
2020-03-31	$-3
2019-12-31	$5
2019-09-30	$-2
2019-06-30	$-3
2019-03-31	$-4
2018-12-31	$-5
2018-09-30	$-5
2018-06-30	$-5
2018-03-31	$-6
2017-12-31	$-5
2017-09-30	$-4
2017-06-30	$-4
2017-03-31	$-4
2016-12-31	$-4
2016-09-30	$-4
2016-06-30	$-4
2016-03-31	$-5
2015-12-31	$-4
2015-09-30	$-5
2015-06-30	$-5
2015-03-31	$-4
2014-12-31	$-4
2014-09-30	$-3
2014-06-30	$-4
2014-03-31	$-3
2013-12-31	$-2
2013-09-30	$-2
2013-06-30	$-2
2013-03-31	$-2
2012-12-31	$-1
2012-09-30	$-2
2012-06-30	$-2
2012-03-31	$-2
2011-12-31	$-2
2011-09-30	$-3
2011-06-30	$-6
2011-03-31	$-4
2010-12-31	$-3
2010-09-30	$-2
2010-06-30	$-3
2010-03-31	$-2
2009-12-31	$-2
2009-09-30	$-1
2009-06-30	$-2
2009-03-31	$-1

Sector	Industry	Market Cap	Revenue
		$0.000B	$0.000B
Ocuphire Pharma Inc. is a clinical-stage ophthalmic biopharmaceutical company. It is focused on developing and commercializing therapies for the treatment of several eye disorders. The company's product pipeline includes Nyxol Eye Drops(R) and APX3330. Ocuphire Pharma Inc., formerly known as Rexahn Pharmaceuticals Inc., is based in FARMINGTON HILLS, Mich.

Stock Name	Country	Market Cap	PE Ratio
Fanhua (AIFU)	China	$0.086B	2.07
Top KingWin (WAI)	China	$0.008B	0.00
S&W Seed (SANW)	United States	$0.006B	0.00
Invo BioScience (NAYA)	United States	$0.004B	0.00